Outcome of Monitoring Committee held on 29.05.2025, for approval of 3rd Quarter and Nine Month ended 31.12.2019 unaudited Standalone & Consolidated Financial Results with limited review report.
Awaiting price reaction for this filing.
Birla Cotsyn (India) Ltd's Monitoring Committee, on May 29, 2025, approved a large batch of overdue financial results spanning FY2018-19 through FY2024-25, including the Q3 and 9-month ended December 31, 2019 unaudited results. The company has been under liquidation since September 2019, but the NCLT approved a Composite Scheme of Compromise and Arrangement on January 9, 2025, allowing revival through an acquirer. For Q3 FY20, revenue from operations was nil (zero), with a loss of Rs. 199.32 lakhs; for the 9 months ended December 31, 2019, the company posted a loss of Rs. 10,082.73 lakhs on total income of just Rs. 844.15 lakhs. Reserves were deeply negative at Rs. (57,247.78) lakhs (standalone). The Committee also approved infusion of Rs. 3 crore working capital and decided to file an application before NCLT against demands raised by MIDC, NSDL, CDSL, and BSE for the CIRP/liquidation period.
This is largely a back-office catch-up filing of old results; no new business momentum. The nil revenue confirms operations remain shut, deep accumulated losses and negative reserves flag a stressed balance sheet, but the NCLT-approved revival scheme and Rs. 3 crore working capital infusion are positive signs for shareholders awaiting the company's restart. Stock may remain thinly traded and volatile until the acquirer's revival plan is fully implemented.